KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS
JCI Insight · 22.05.2026 · 11 (10)
DOI: 10.1172/jci.insight.197941 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 26.03.2026. Verfasst von Tetsuya Akiyama und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Kinesins, Amyotrophic Lateral Sclerosis, Survival of Motor Neuron 1 Protein, Muscular Atrophy, Spinal. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, NIH HHS.
Abstract (Originalsprache)
Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder caused by mutations in the survival motor neuron 1 ( SMN1 ) gene leading to decreased SMN protein levels and motor neuron dysfunction. SMN-restoring therapies offer clinical benefit, but the downstream molecular consequences of SMN reduction remain incompletely understood. SMN deficiency resulted in downregulation of kinesin heavy chain isoform 5A (KIF5A) in human neurons and in a mouse model of SMA. SMN associated with KIF5A mRNA and contributed to its stability. Reduced SMN levels impaired axon regeneration, which was rescued by KIF5A overexpression. Because KIF5A has also been connected to ALS, these findings provide evidence of a molecular link between SMA and ALS pathophysiology, highlighting KIF5A as an SMN-regulated factor. Our findings suggest that SMN-independent interventions targeting KIF5A could represent a complementary therapeutic approach for SMA and other motor neuron diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Stanford University School of Medicine, Stanford, California, USA.
- Stanford Neurosciences Graduate Program.
- Department of Neurology and Neurological Sciences, and.
- Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California, USA.
- Department of Neurology and.
- Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Akiyama, T., Zeng, Y., Guo, C., Gautier, O., Koepke, L., Lyons, H., Molotsky, E., Bombosch, J. S., Sianto, O., Ross, J. P., Hoang, P., Zhao, L., Spencer, C., Sumner, C. J., Monje, M., Day, J. W., & Gitler, A. D. (2026). KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS. JCI Insight, 11(10). https://doi.org/10.1172/jci.insight.197941
Vancouver
Akiyama T, Zeng Y, Guo C, Gautier O, Koepke L, Lyons H, et al. KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS. JCI Insight. 2026;11(10). doi:10.1172/jci.insight.197941
BibTeX
@article{Akiyama2026,
author = {Akiyama, Tetsuya and Zeng, Yi and Guo, Caiwei and Gautier, Olivia and Koepke, Lauren and Lyons, Heankel and Molotsky, Elana and Bombosch, Juliane S and Sianto, Odilia and Ross, Jay P and Hoang, Phuong and Zhao, Luke and Spencer, Cole and Sumner, Charlotte J and Monje, Michelle and Day, John W and Gitler, Aaron D},
title = {KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {10},
doi = {10.1172/jci.insight.197941}
}
EUVIMED